Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Grimwade

Showing results (31-40 of 104) with videos related to

Pageof 11
Sort By:
European Journal of Haematology|June 26, 2015
Leukemia diagnosis: today and tomorrowMarie C Béné, David Grimwade, Claudia Haferlach, et al.
Annals of the New York Academy of Sciences|February 6, 2014
Topoisomerase II and leukemiaMaryjean Pendleton, R Hunter Lindsey, Carolyn A Felix, et al.
Pediatric Blood & Cancer|April 9, 2009
Central nervous system involvement in relapsed acute promyelocytic leukemiaGertjan Kaspers, Brenda Gibson, David Grimwade, et al.
Blood|January 30, 2015
Minimal residual disease-directed therapy in acute myeloid leukemiaSabine Kayser, Richard F Schlenk, David Grimwade, et al.
Frontiers in Bioscience (Landmark Edition)|March 11, 2009
PML nuclear bodies in the pathogenesis of acute promyelocytic leukemia: active players or innocent bystanders?Nicola J M Brown, Michal Ramalho, Eva W Pedersen, et al.
The EMBO Journal|June 4, 2013
The epigenetic regulator PLZF represses L1 retrotransposition in germ and progenitor cellsWilliam Puszyk, Thomas Down, David Grimwade, et al.
Blood|August 12, 2018
Attenuated arsenic trioxide plus ATRA therapy for newly diagnosed and relapsed APL: long-term follow-up of the AML17 trialNigel Russell, Alan Burnett, Robert Hills, et al.
Frontiers in Oncology|June 2, 2012
Development of real-time quantitative polymerase chain reaction assays to track treatment response in retinoid resistant acute promyelocytic leukemiaJelena V Jovanovic, Kristian Rennie, Dominic Culligan, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|September 24, 2017
The Cks1/Cks2 axis fine-tunes Mll1 expression and is crucial for MLL-rearranged leukaemia cell viabilityWilliam Grey, Adam Ivey, Thomas A Milne, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 25, 2013
Prognostic relevance of treatment response measured by flow cytometric residual disease detection in older patients with acute myeloid leukemiaSylvie D Freeman, Paul Virgo, Steve Couzens, et al.
Pageof 11

Showing results (31-40 of 104) with videos related to

Sort By:
Pageof 11
European Journal of Haematology|June 26, 2015
Leukemia diagnosis: today and tomorrowMarie C Béné, David Grimwade, Claudia Haferlach, et al.
Annals of the New York Academy of Sciences|February 6, 2014
Topoisomerase II and leukemiaMaryjean Pendleton, R Hunter Lindsey, Carolyn A Felix, et al.
Pediatric Blood & Cancer|April 9, 2009
Central nervous system involvement in relapsed acute promyelocytic leukemiaGertjan Kaspers, Brenda Gibson, David Grimwade, et al.
Blood|January 30, 2015
Minimal residual disease-directed therapy in acute myeloid leukemiaSabine Kayser, Richard F Schlenk, David Grimwade, et al.
Frontiers in Bioscience (Landmark Edition)|March 11, 2009
PML nuclear bodies in the pathogenesis of acute promyelocytic leukemia: active players or innocent bystanders?Nicola J M Brown, Michal Ramalho, Eva W Pedersen, et al.
The EMBO Journal|June 4, 2013
The epigenetic regulator PLZF represses L1 retrotransposition in germ and progenitor cellsWilliam Puszyk, Thomas Down, David Grimwade, et al.
Blood|August 12, 2018
Attenuated arsenic trioxide plus ATRA therapy for newly diagnosed and relapsed APL: long-term follow-up of the AML17 trialNigel Russell, Alan Burnett, Robert Hills, et al.
Frontiers in Oncology|June 2, 2012
Development of real-time quantitative polymerase chain reaction assays to track treatment response in retinoid resistant acute promyelocytic leukemiaJelena V Jovanovic, Kristian Rennie, Dominic Culligan, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|September 24, 2017
The Cks1/Cks2 axis fine-tunes Mll1 expression and is crucial for MLL-rearranged leukaemia cell viabilityWilliam Grey, Adam Ivey, Thomas A Milne, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 25, 2013
Prognostic relevance of treatment response measured by flow cytometric residual disease detection in older patients with acute myeloid leukemiaSylvie D Freeman, Paul Virgo, Steve Couzens, et al.
Pageof 11